Evidence map›Paper›PMID 41777833›Full record

ArticleRSC advances2026

Fe

Bin Jia, Yimu Zhong, Danyang Zhai, Jing Pang, Bo Sha, Na Li, Bo Li, Wenting Liang, Wei Bian

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bin JiaDepartment of Chemistry, School of Basic Medical Science, Shanxi Medical University Taiyuan 030001 China bjia2006@163.com.
Yimu ZhongDepartment of Chemistry, School of Basic Medical Science, Shanxi Medical University Taiyuan 030001 China bjia2006@163.com.
Danyang ZhaiDepartment of Chemistry, School of Basic Medical Science, Shanxi Medical University Taiyuan 030001 China bjia2006@163.com.
Jing PangDepartment of Chemistry, School of Basic Medical Science, Shanxi Medical University Taiyuan 030001 China bjia2006@163.com.
Bo ShaDepartment of Chemistry, School of Basic Medical Science, Shanxi Medical University Taiyuan 030001 China bjia2006@163.com.
Na LiDepartment of Chemistry, School of Basic Medical Science, Shanxi Medical University Taiyuan 030001 China bjia2006@163.com.
Bo LiDepartment of Chemistry, School of Basic Medical Science, Shanxi Medical University Taiyuan 030001 China bjia2006@163.com.
Wenting LiangInstitute of Environmental Science, Department of Chemistry, Shanxi University Taiyuan 030006 China.ORCID https://orcid.org/0000-0002-3275-9965
Wei BianDepartment of Chemistry, School of Basic Medical Science, Shanxi Medical University Taiyuan 030001 China bjia2006@163.com.ORCID https://orcid.org/0000-0002-7898-9571

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy consistently exhibits constrained therapeutic efficacy due to inadequate tumor specificity and unavoidable multidrug resistance. However, the development of nanoscale drug carrier systems offers a promising therapeutic approach for cancer treatment, given their proven potential in targeted delivery and synergistic therapeutic outcomes. In this work, nanoparticles (NPs) designed for drug delivery and photothermal therapy (PTT) were fabricated by grafting hyaluronic acid (HA) and folic acid (FA) onto the surface of Fe

Identifiers

PMID41777833
PMCPMC12951213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.